Successful outcome of allo-SCT in high-risk pediatric AML using chemotherapy-only conditioning and post transplant immunotherapy. [electronic resource]
Producer: 20081014Description: 253-7 p. digitalISSN:- 0268-3369
- Alemtuzumab
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized
- Antibodies, Neoplasm -- therapeutic use
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Busulfan -- therapeutic use
- Child
- Child, Preschool
- Combined Modality Therapy
- Cyclophosphamide -- therapeutic use
- Cyclosporine -- therapeutic use
- Female
- Graft vs Host Disease -- prevention & control
- Humans
- Immunotherapy
- Infant
- Leukemia, Myeloid, Acute -- drug therapy
- Male
- Melphalan -- therapeutic use
- Stem Cell Transplantation -- methods
- Transplantation Chimera -- immunology
- Transplantation Conditioning -- methods
- Transplantation, Homologous
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.